Timing of breast cancer surgery within the menstrual cycle: Tumor proliferative activity, receptor status and short-term clinical outcome

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 3, 1998, Pages 317-323

  Mangia, A ^a   De Lena, M ^a   Barletta, A ^a   Marzullo, F ^a   Attolico, M ^a   Stea, B ^a   Petroni, S ^a   Labriola, A ^a   Cellamare, G ^a   Digiesi, G ^a   Altieri, R ^a   Schittulli, F ^a   Paradiso, A ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Breast cancer; DNA status; Hormone receptors; Menstrual cycle; Proliferative activity

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; THYMIDINE; TRITIUM;

ADULT; ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MASTECTOMY; MENSTRUAL CYCLE; PRIORITY JOURNAL; TIME; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032469772     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ratajczak H.V., Sothern R.B., Hrushesky W.M. Estrous influence on surgical cure of a mouse breast cancer. J. Exp. Med. 168: 73-83. 1988.
2. Fisher B., Gunouz N., Coyle J., Rudock C., Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 49: 1996-2000, 1989.
3. Fentiman I., Gregory W.M., Richards M.A. Effect of menstrual phase on surgical treatment of breast cancer. Lancet 344: 401, 1994.
4. Vanek V.W., Kadivar T.F., Bourguet C.C. Correlation of menstrual cycle at time of breast cancer surgery to disease-free and overall survival. South. Med. J. 90(8): 780-788, 1997.
5. Oliver D.J., Ingram D.M. Timing of surgery during the menstrual cycle for breast cancer: possible role of growth factors. Eur. J. Cancer 31A: 325-328, 1995.
6. Hanna N., Schneider M. Enhancement of tumour metastasis and suppression of natural killer cell activity by -oestradiol treatment. J. Immunol. 130: 947-980, 1983.
7. Tedone T., Correale M., Paradiso A., Reshkin S.J. Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7. Eur. J. Cancer 32(5): 849-856, 1996.
8. Lippman M.E., Fickson R.B., Bates S., et al. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat. 7: 59-70, 1986.
9. Relia C., Coviello M., Quaranta M., Paradiso A. Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer. Thrombosis Res. 69: 209-220, 1993.
10. Saad Z., Vincent M., Bramwell V., et al. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer. Eur. J. Cancer 30A(9): 1348-1352, 1994.
11. Badwe R.A., Bettelheim R., Millis R.R., Gregory W., Richards M.A., Fentiman I.S. Cyclical tumour variations in premenopausal women with early breast cancer. Eur J Cancer 31A(13-14): 2181-2184, 1995.
12. Olsson H., Jernström H., Alm P., et al. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res. and Treat. 40: 187-196, 1996.
13. Potten CS, Watson RJ, Williams GT, et al. The effect of age and the menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer 58: 163-170, 1988.
14. Paradiso A., Mangia A., Barletta A. et al. Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects: Eur. J. Cancer 31A(6): 911-916, 1995.
15. Fisher E.R., Redmond C., Fisher B. Histologic Grading of Breast Cancer. Pathol. Ann. 1(15): 239-251, 1980.
16. Jager W., Sauerbrei W. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients. Breast Cancer Res. Treat. 34: 279-287, 1995.
17. Veronesi U., Luini A., Mariani L., et al. Effect of menstrual phase of surgical treatment of breast cancer. Lancet 343: 1545-1547, 1994.
18. EORTC Breast Cancer Cooperative Group. Revision of the Standards for the assessment of hormone receptor in human breast cancer. Eur. J. Cancer 16: 1513-1515, 1980.
19. Smyth C.M., Benn D.E., Reeve T.S. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies. Breast Cancer Res. Treat. 11: 45-50, 1988.
20. Silva J.S., Cox E.B., Leight G.S., et al. Effects of menstrual cycle on estrogen receptor levels in human breast cancer. Proc. ASCO 2: C-31, 1983.
21. Rageth J.C., Wyss P., Unger C., Hochuli E. Timing of breast cancer surgery within the menstrual cycle: Influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence. Ann. Oncol. 2: 269-272, 1991.
22. Axelrod D.M., Menendez-Botet C.J., Kinne D.W., Osborne M.P. Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses. Cancer Invest. 6: 7-14, 1988.
23. Weimer D.A., Donegan W.L. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle. Breast Cancer Res. Treat. 10: 273-278, 1987.
24. Von Minchwitz G., Grischke E.M., Kaufmann M. Effect of menstrual phase on surgical treatment of breast cancer. Lancet 344: 403, 1994.
25. Yen Samuel S.C., Jaffe R.B. The human menstrual cycle in reproductive endocrinology. Philadelphia, WB Saunders,1986, pp. 126-151.
26. Saad Z., Bramwell V., Duff J., et al. Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br. J. Surg. 81: 217-220, 1994.
27. Kim J.S., Rha S.Y., Chung H.C., et al. Changes in serum VEGF, Angiogenin, PDGF and BFGF levels between follicular and luteal phases of normal menstruation and postmenopausal state of healthy women. Breast Cancer Res. Treat. 41(3): 241, 1996.
28. Levine J.M., Myles J., Shepherd L., Elkum N. Optimal timing of breast cancer surgery within the menstrual cycle: Results from a prospective trial. Proc. ASCO 15: 99, 1996.